Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Joni Mitchell’s Morgellons Battle Aided by Research from Charles E. Holman Morgellons Disease Foundation
  • USA - English


News provided by

The Charles E. Holman Foundation

Apr 07, 2015, 09:55 ET

Share this article

Share toX

Share this article

Share toX

Joni Mitchell and The Charles E. Holman Morgellons Disease Foundation
Joni Mitchell and The Charles E. Holman Morgellons Disease Foundation

Austin, TX (PRWEB) April 07, 2015 -- Joni Mitchell’s emergency hospitalization last week has people talking about the controversial disease she has been reporting for years. Many in the medical community continue to think it is a delusional condition despite research funded by The Charles E. Holman Morgellons Disease Foundation (CEHMDF) that is published in peer-reviewed medical journals. (1)

It is sad that Joni Mitchell's talent and health had to be place in jeopardy for the reality and facts of Morgellons to be in the spotlight.

Post this

Morgellons Disease (MD) is a multi-system illness uniquely characterized by the formation of unusual fibers within the skin. MD is a debilitating, and often misunderstood, condition consisting of slow-healing skin lesions, overwhelming fatigue, GI disturbances and an array of neurological deficits.

A growing list of scientific studies proves that Morgellons disease is real. (1) At the recent Morgellons Medical Conference in Austin, TX, scientists from around the world presented evidence substantiating Morgellons disease to be a true medical illness and identified bacterial pathogens involved. "These patients suffer from a miserable chronic illness, and the medical establishment's response is to kick them in the teeth," said Dr. Raphael Stricker, a San Francisco internist with over 100 Morgellons patients in his practice. "The sad part is that when these patients are treated properly, they can recover."

Microbiologist Marianne Middelveen from Canada presented study research data showing that the fibers in skin lesions from Morgellons patients are real. (2) "These are not clothing or textile fibers, but something made by the patient's own cells," said Middelveen. "In essence, the body is overproducing these weird fibers." (2)

Virginia Savely, DNP has treated approximately 800 patients with Morgellons and has studied it for over 13 years. She states, “Any doctor who calls Morgellons a psychiatric condition has clearly not looked carefully at the skin with 60-100x lighted magnification and seen the characteristic fibers woven below the outer surface of intact skin. These patients are sick with a painful, debilitating illness and diagnosing them as delusional is nothing less than malpractice. Morgellons is a very real infection that responds to antibiotic treatment.”

The publicity surrounding Morgellons has dimmed since the 2012 CDC report. Theirs was a very preliminary effort to investigate this emerging infectious disease according to the CEHMDF. The $334,000 provided to the CDC by the US Government was an unfortunate waste of taxpayer dollars. As expected, the study offered no new insights and led many to believe the door was closed on this topic.

Close the door? The Holman Foundation along with thousands of suffering victims didn’t think so. Even the CDC admitted “.... We were not able to conclude based on this study whether this unexplained dermopathy represents a new condition, as has been proposed by those who use the term Morgellons, or wider recognition of an existing condition such as delusional infestation, with which it shares a number of clinical and epidemiologic features [26–31].” (3) Recommendations from the often-ignored Report of the External Peer Review of CCID’s Unexplained Dermopathy (UD) Project included these suggestions:”What should the priorities be in the future? … Physicians encountering patients who may have this condition should be encouraged to publish in a peer-reviewed medical journal a description of a carefully documented case. Photographs of fibers extruding from (or present within) normal intact skin, detailed histopathologic examination of biopsied skin specimens, and thorough analysis of the fibers will be especially helpful in clarifying several lingering questions.…” (3)

The CDC panel’s suggestion to continue researching Morgellons and publish in peer-reviewed medical journals is exactly what the Holman Foundation has done and will continue to do. It is sad that Joni Mitchell's talent and health had to be place in jeopardy for the reality and facts of Morgellons to be in the spotlight. “Denial of Morgellons disease will go down in history as one of the most shameful acts of unethical conduct by our nation's health agencies and medical system.” Cindy Casey-Holman, RN, Director of the CEHMDF.

About The Charles E. Holman Morgellons Disease Foundation
The Charles E. Holman Morgellons Disease Foundation is a 501©3 nonprofit committed to advocacy and philanthropy in the battle against MD. An all-volunteer organization based in Austin, TX, the Holman foundation is the singularly recognized authority on Morgellons disease and stands alone in funding scientific research of this condition. Executive Director Cindy Casey-Holman, RN leads the foundation, named for Charles E. Holman, a pioneer in the fight against MD. Currently, there exist neither grants, nor any other public or private funding sources to support research for this disease.

1. Thecehf.org,. 'Morgellons Disease Research | The CEHF'. N.p., 2015. Web. 7 Apr. 2015.
2. Middelveen, Marianne J et al. 'Exploring The Association Between Morgellons Disease And Lyme Disease: Identification Of Borrelia Burgdorferi In Morgellons Disease Patients'. BMC Dermatology 15.1 (2015): n. pag. Web. 7 Apr. 2015.
3. http://www.cdc.gov,.http://www.cdc.gov/unexplaineddermopathy/docs/external_peer_review.pdf - .N.p., 2015. Web. 7 Apr. 2015.
##

GWEN SIMMONS, The Charles E. Holman Foundation, +1 (901) 252-7494, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.